 | • レポートコード：GIR-23F3901 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の豚繁殖性呼吸器症候群（PRRS）ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 豚繁殖性呼吸器症候群（PRRS）ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・生ワクチン、不活化ワクチン アプリケーション別セグメントは次のように区分されます。 ・政府入札、市場販売 世界の豚繁殖性呼吸器症候群（PRRS）ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・CAHIC、Merial、MSD Animal Health、Chopper Biology、Ceva、ChengDu Tecbond、Veterinary、Ringpu Biology、Qilu Animal、DHN、CAVAC、Komipharm、Agrovet、Bioveta、Jinyu Bio-Technology、Institutul Pasteur、MVP、Tecon、Zoetis 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 豚繁殖性呼吸器症候群（PRRS）ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：生ワクチン、不活化ワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：政府入札、市場販売 - 世界の豚繁殖性呼吸器症候群（PRRS）ワクチン市場規模・予測 - 世界の豚繁殖性呼吸器症候群（PRRS）ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - CAHIC、Merial、MSD Animal Health、Chopper Biology、Ceva、ChengDu Tecbond、Veterinary、Ringpu Biology、Qilu Animal、DHN、CAVAC、Komipharm、Agrovet、Bioveta、Jinyu Bio-Technology、Institutul Pasteur、MVP、Tecon、Zoetis ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：生ワクチン、不活化ワクチン ・アプリケーション別分析2017年-2028年：政府入札、市場販売 ・豚繁殖性呼吸器症候群（PRRS）ワクチンの北米市場分析 - 豚繁殖性呼吸器症候群（PRRS）ワクチンの北米市場：タイプ別市場規模2017年-2028年 - 豚繁殖性呼吸器症候群（PRRS）ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・豚繁殖性呼吸器症候群（PRRS）ワクチンのヨーロッパ市場分析 - ：豚繁殖性呼吸器症候群（PRRS）ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：豚繁殖性呼吸器症候群（PRRS）ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・豚繁殖性呼吸器症候群（PRRS）ワクチンのアジア太平洋市場分析 - 豚繁殖性呼吸器症候群（PRRS）ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 豚繁殖性呼吸器症候群（PRRS）ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・豚繁殖性呼吸器症候群（PRRS）ワクチンの南米市場分析 - 豚繁殖性呼吸器症候群（PRRS）ワクチンの南米市場：タイプ別市場規模2017年-2028年 - 豚繁殖性呼吸器症候群（PRRS）ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・豚繁殖性呼吸器症候群（PRRS）ワクチンの中東・アフリカ市場分析 - 豚繁殖性呼吸器症候群（PRRS）ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 豚繁殖性呼吸器症候群（PRRS）ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Government Tender accounting for % of the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, and Ceva, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Killed Vaccines
Market segment by Application can be divided into
Government Tender
Market Sales
The key market players for global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market are listed below:
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, with price, sales, revenue and global market share of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines from 2019 to 2022.
Chapter 3, the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.
Chapter 13, 14, and 15, to describe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size & Forecast
1.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume (2017-2028)
1.4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (2017-2028)
1.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity Analysis
1.5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
1.6.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
1.6.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 CAHIC
2.1.1 CAHIC Details
2.1.2 CAHIC Major Business
2.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merial
2.2.1 Merial Details
2.2.2 Merial Major Business
2.2.3 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.2.4 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 MSD Animal Health
2.3.1 MSD Animal Health Details
2.3.2 MSD Animal Health Major Business
2.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Chopper Biology
2.4.1 Chopper Biology Details
2.4.2 Chopper Biology Major Business
2.4.3 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.4.4 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ceva
2.5.1 Ceva Details
2.5.2 Ceva Major Business
2.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 ChengDu Tecbond
2.6.1 ChengDu Tecbond Details
2.6.2 ChengDu Tecbond Major Business
2.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Veterinary
2.7.1 Veterinary Details
2.7.2 Veterinary Major Business
2.7.3 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.7.4 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ringpu Biology
2.8.1 Ringpu Biology Details
2.8.2 Ringpu Biology Major Business
2.8.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.8.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Qilu Animal
2.9.1 Qilu Animal Details
2.9.2 Qilu Animal Major Business
2.9.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.9.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 DHN
2.10.1 DHN Details
2.10.2 DHN Major Business
2.10.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.10.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 CAVAC
2.11.1 CAVAC Details
2.11.2 CAVAC Major Business
2.11.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.11.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Komipharm
2.12.1 Komipharm Details
2.12.2 Komipharm Major Business
2.12.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.12.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Agrovet
2.13.1 Agrovet Details
2.13.2 Agrovet Major Business
2.13.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.13.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Bioveta
2.14.1 Bioveta Details
2.14.2 Bioveta Major Business
2.14.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.14.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Jinyu Bio-Technology
2.15.1 Jinyu Bio-Technology Details
2.15.2 Jinyu Bio-Technology Major Business
2.15.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.15.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Institutul Pasteur
2.16.1 Institutul Pasteur Details
2.16.2 Institutul Pasteur Major Business
2.16.3 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.16.4 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 MVP
2.17.1 MVP Details
2.17.2 MVP Major Business
2.17.3 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.17.4 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Tecon
2.18.1 Tecon Details
2.18.2 Tecon Major Business
2.18.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.18.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Zoetis
2.19.1 Zoetis Details
2.19.2 Zoetis Major Business
2.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
2.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Breakdown Data by Manufacturer
3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturer Market Share in 2021
3.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region
4.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2028)
4.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028)
4.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028)
4.5 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2017-2028)
5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2017-2028)
6.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2028)
7.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2028)
7.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
7.3.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2028)
8.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2028)
8.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
8.3.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region
9.3.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2028)
10.2 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2028)
10.3 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
10.3.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
11.3.1 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
12.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Process
12.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Typical Distributors
13.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CAHIC Basic Information, Manufacturing Base and Competitors
Table 4. CAHIC Major Business
Table 5. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 6. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merial Basic Information, Manufacturing Base and Competitors
Table 8. Merial Major Business
Table 9. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 10. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 12. MSD Animal Health Major Business
Table 13. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 14. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Chopper Biology Basic Information, Manufacturing Base and Competitors
Table 16. Chopper Biology Major Business
Table 17. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 18. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Ceva Basic Information, Manufacturing Base and Competitors
Table 20. Ceva Major Business
Table 21. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 22. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 24. ChengDu Tecbond Major Business
Table 25. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 26. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Veterinary Basic Information, Manufacturing Base and Competitors
Table 28. Veterinary Major Business
Table 29. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 30. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 32. Ringpu Biology Major Business
Table 33. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 34. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Qilu Animal Basic Information, Manufacturing Base and Competitors
Table 36. Qilu Animal Major Business
Table 37. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 38. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. DHN Basic Information, Manufacturing Base and Competitors
Table 40. DHN Major Business
Table 41. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 42. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. CAVAC Basic Information, Manufacturing Base and Competitors
Table 44. CAVAC Major Business
Table 45. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 46. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Komipharm Basic Information, Manufacturing Base and Competitors
Table 48. Komipharm Major Business
Table 49. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 50. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Agrovet Basic Information, Manufacturing Base and Competitors
Table 52. Agrovet Major Business
Table 53. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 54. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Bioveta Basic Information, Manufacturing Base and Competitors
Table 56. Bioveta Major Business
Table 57. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 58. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 60. Jinyu Bio-Technology Major Business
Table 61. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 62. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Institutul Pasteur Basic Information, Manufacturing Base and Competitors
Table 64. Institutul Pasteur Major Business
Table 65. Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 66. Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. MVP Basic Information, Manufacturing Base and Competitors
Table 68. MVP Major Business
Table 69. MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 70. MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Tecon Basic Information, Manufacturing Base and Competitors
Table 72. Tecon Major Business
Table 73. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 74. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Zoetis Basic Information, Manufacturing Base and Competitors
Table 76. Zoetis Major Business
Table 77. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 78. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 80. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 83. Head Office and Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Site of Key Manufacturer
Table 84. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines New Entrant and Capacity Expansion Plans
Table 85. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Mergers & Acquisitions in the Past Five Years
Table 86. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2017-2022) & (K Units)
Table 87. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2023-2028) & (K Units)
Table 88. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)
Table 91. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2023-2028) & (K Units)
Table 92. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 95. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 96. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)
Table 97. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2023-2028) & (K Units)
Table 98. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 101. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 102. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)
Table 103. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2023-2028) & (K Units)
Table 104. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)
Table 107. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2023-2028) & (K Units)
Table 108. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)
Table 109. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2023-2028) & (K Units)
Table 110. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)
Table 111. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2023-2028) & (K Units)
Table 112. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)
Table 115. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2023-2028) & (K Units)
Table 116. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)
Table 117. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2023-2028) & (K Units)
Table 118. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2017-2022) & (K Units)
Table 119. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2023-2028) & (K Units)
Table 120. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)
Table 123. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2023-2028) & (K Units)
Table 124. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)
Table 125. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2023-2028) & (K Units)
Table 126. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)
Table 127. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2023-2028) & (K Units)
Table 128. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)
Table 131. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2023-2028) & (K Units)
Table 132. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)
Table 133. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2023-2028) & (K Units)
Table 134. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2017-2022) & (K Units)
Table 135. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2023-2028) & (K Units)
Table 136. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)
Table 139. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2023-2028) & (K Units)
Table 140. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2017-2022) & (K Units)
Table 141. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2023-2028) & (K Units)
Table 142. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Raw Material
Table 143. Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Typical Distributors
Table 147. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Typical Customers
List of Figures
Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Picture
Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application in 2021
Figure 6. Government Tender
Figure 7. Market Sales
Figure 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2017-2028) & (K Units)
Figure 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (2017-2028) & (USD/Unit)
Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity (2017-2028) & (K Units)
Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
Figure 15. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
Figure 16. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Trends
Figure 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturer in 2021
Figure 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturer in 2021
Figure 19. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2028)
Figure 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2017-2028)
Figure 24. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028) & (USD Million)
Figure 25. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2028)
Figure 36. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2028)
Figure 38. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2028)
Figure 39. United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2028)
Figure 45. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2028)
Figure 46. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2017-2028)
Figure 55. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2028)
Figure 62. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2028)
Figure 63. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2028)
Figure 64. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in 2021
Figure 76. Manufacturing Process Analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
Figure 77. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source